Suppr超能文献

一名患有原发性血小板增多症的孕妇中JAK2V617F突变与BCR-ABL易位并存。

Coexistence of JAK2V617F Mutation and BCR-ABL Translocation in a Pregnant Woman with Essential Thrombocythemia.

作者信息

Qin You-Wen, Yang Yi-Ning, Li Su, Wang Chun

机构信息

Department of Hematology, Shanghai First People's Hospital, Medical College, Shanghai JiaoTong University, Shanghai, People's Republic of China.

出版信息

Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):331-4. doi: 10.1007/s12288-014-0385-1. Epub 2014 Apr 11.

Abstract

In 2012, a 25-years-old pregnant woman presented with thromocytosis for 4 months, blood counts showed platelets 701 × 10(9)/L. Bone marrow examination disclosed a feature of hypercellular marrow in erythrocytic,granulocytic and megakaryocytic series. Cytogenetic analysis showed t(9;22)(q34;q11) in 100 % of metaphase. The percentage of BCR-ABL-positive FISH signals was 37 % in the peripheral blood. Molecular analysis showed the presence of the JAK2V617F mutation and BCR-ABL mRNA b3a2 transcript. A diagnosis of concomitant presence of essential thrombocythemia and chronic myelocytic leukemia was made. Based on this case and literatures reported before, it might be necessary to detect JAK2-V617F mutation and BCR-ABL fusion gene concomitantly in myeloproliferative neoplasms patients.

摘要

2012年,一名25岁的孕妇出现血小板增多症4个月,血细胞计数显示血小板为701×10⁹/L。骨髓检查显示红细胞系、粒细胞系和巨核细胞系骨髓细胞增多。细胞遗传学分析显示100%的中期细胞存在t(9;22)(q34;q11)。外周血中BCR-ABL阳性FISH信号的百分比为37%。分子分析显示存在JAK2V617F突变和BCR-ABL mRNA b3a2转录本。诊断为原发性血小板增多症和慢性粒细胞白血病并存。基于该病例及之前报道的文献,在骨髓增殖性肿瘤患者中可能有必要同时检测JAK2-V617F突变和BCR-ABL融合基因。

相似文献

1
Coexistence of JAK2V617F Mutation and BCR-ABL Translocation in a Pregnant Woman with Essential Thrombocythemia.
Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):331-4. doi: 10.1007/s12288-014-0385-1. Epub 2014 Apr 11.
2
Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera.
Med Oncol. 2011 Dec;28(4):1555-8. doi: 10.1007/s12032-010-9570-8. Epub 2010 May 25.
4
Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.
Diagn Mol Pathol. 2012 Sep;21(3):176-83. doi: 10.1097/PDM.0b013e318246975e.
7
is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia.
Blood Sci. 2022 Aug 1;4(4):199-204. doi: 10.1097/BS9.0000000000000129. eCollection 2022 Oct.
9
Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation.
Int J Hematol. 2014 Jan;99(1):87-90. doi: 10.1007/s12185-013-1480-z. Epub 2013 Nov 30.

本文引用的文献

3
Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.
Diagn Mol Pathol. 2012 Sep;21(3):176-83. doi: 10.1097/PDM.0b013e318246975e.
4
Concomitant occurrence of BCR-ABL and JAK2V617F mutation.
Blood. 2011 Sep 22;118(12):3445-6. doi: 10.1182/blood-2011-07-365007.
5
Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera.
Med Oncol. 2011 Dec;28(4):1555-8. doi: 10.1007/s12032-010-9570-8. Epub 2010 May 25.
7
A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders.
Int J Hematol. 2010 Jan;91(1):136-9. doi: 10.1007/s12185-009-0471-6. Epub 2010 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验